Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ELVN
- Price
- 16.51
- Stock movement up
- +1.60 (10.73%)
- Company name
- Enliven Therapeutics Inc.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 806.67M
- Ent value
- 723.07M
- Price/Sales
- 1833.33
- Price/Book
- 2.80
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 10.90%
- 1 year return
- -16.70%
- 3 year return
- -2.69%
- 5 year return
- -42.20%
- 10 year return
- -
Last updated: 2025-04-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ELVN does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1833.33 |
| Price to Book | 2.80 |
| EV to Sales | 1643.34 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 48.86M |
| EPS (TTM) | -1.77 |
| FCF per share (TTM) | -2.41 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 440.00K |
| Gross profit (TTM) | 205.00K |
| Operating income (TTM) | -100.39M |
| Net income (TTM) | -85.21M |
| EPS (TTM) | -1.77 |
| EPS (1y forward) | -2.25 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 46.59% |
| Operating margin (TTM) | -22815.23% |
| Profit margin (TTM) | -19366.82% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 100.62M |
| Net receivables | 0.00 |
| Total current assets | 297.00M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 1.54M |
| Total assets | 305.43M |
| Accounts payable | 1.02M |
| Short/Current long term debt | 85.00K |
| Total current liabilities | 17.03M |
| Total liabilities | 17.03M |
| Shareholder's equity | 288.40M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -116.46M |
| Capital expenditures (TTM) | 58.00K |
| Free cash flow (TTM) | -116.52M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -29.55% |
| Return on Assets | -27.90% |
| Return on Invested Capital | -29.54% |
| Cash Return on Invested Capital | -40.39% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 15.06 |
| Daily high | 16.54 |
| Daily low | 14.45 |
| Daily Volume | 327K |
| All-time high | 877.92 |
| 1y analyst estimate | 37.86 |
| Beta | - |
| EPS (TTM) | -1.77 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 12 May 2025 |
Downside potential
Loading...
Downside potential data
| ELVN | S&P500 | |
| Current price drop from All-time high | -98.12% | -12.89% |
| Highest price drop | -98.85% | -56.47% |
| Date of highest drop | 12 Dec 2023 | 9 Mar 2009 |
| Avg drop from high | -86.06% | -11.07% |
| Avg time to new high | 67 days | 12 days |
| Max time to new high | 1216 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
806.67M
Marketcap category
Small-cap
Description
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. The company is headquartered in Boulder, Colorado.
Employees
46
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page